[LGND] QoQ Quarter Result on 31-Dec-2015 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
26-Feb-2016
Financial Year
2015
Quarter
31-Dec-2015 [#Q4]
Profit Trend
QoQ- -96.82%
YoY- -10.12%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
Revenue 21,619 19,521 29,648 21,192 17,701 18,418 14,602 29.80%
PBT 804 -9,644 9,571 5,826 7,284 22,292 -74 -
Tax 160 -3,881 3,694 -515 -217,255 265 15 382.48%
NP 644 -5,763 6,608 6,341 199,165 23,564 754 -9.95%
Tax Rate -19.90% - -38.60% 8.84% 2,982.63% -1.19% - -
Total Cost 20,975 25,284 23,040 14,851 -181,464 -5,146 13,848 31.78%
Ratio Analysis
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
NP Margin 2.98 -29.52 22.29 29.92 1,125.16 127.94 5.16 -30.58%
Per Share
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
EPS 0.03 -0.28 0.32 0.32 10.01 1.19 0.04 -17.40%
EPS Diluted 0.03 -0.28 0.30 0.29 9.28 1.11 0.04 -17.40%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.